0000899243-20-032772.txt : 20201204 0000899243-20-032772.hdr.sgml : 20201204 20201204173807 ACCESSION NUMBER: 0000899243-20-032772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniel Jennifer CENTRAL INDEX KEY: 0001797725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 201370809 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-03 0 0001490978 Schrodinger, Inc. SDGR 0001797725 Daniel Jennifer C/O SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2020-12-03 4 M 0 1923 4.34 A 8611 D Common Stock 2020-12-03 4 M 0 10033 3.07 A 18644 D Common Stock 2020-12-03 4 S 0 5289 65.0896 D 13355 D Common Stock 2020-12-03 4 S 0 6667 66.0049 D 6688 D Stock Option (right to buy) 4.34 2020-12-03 4 M 0 1923 0.00 D 2028-11-29 Common Stock 1923 14296 D Stock Option (right to buy) 3.07 2020-12-03 4 M 0 10033 0.00 D 2027-04-07 Common Stock 10033 36788 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.59 to $65.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.60 to $66.47, inclusive. This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022. This option was granted on April 7, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from February 22, 2017 through February 22, 2021. Senior Vice President and Chief Human Resources Officer /s/ Donald Shum, as attorney-in-fact for Jennifer Daniel 2020-12-04